EP212: The Current State of Standardizing Cancer Care With Pathways, With Kathy Lokay From Via Oncology
Relentless Health Value™January 24, 2019
212
27:4638.14 MB

EP212: The Current State of Standardizing Cancer Care With Pathways, With Kathy Lokay From Via Oncology

Kathy Lokay is general manager, as well as chief cheerleader and idea generator, for Via Oncology. Kathy joined UPMC in 2008 to launch the Via Oncology product that UPMC CancerCenter started in 2004. Her background as a CPA combined with her 20 years of experience in oncology have been a great foundation to help her lead Via’s overall strategy and execution. She is passionate about driving the volume to value transition in oncology and has made clinical pathways her personal mission for the past 11 years. Kathy was previously senior vice president at US Oncology with responsibility for several business units. She received her Bachelor of Business Administration in accounting from the University of Texas.


02:15 Evidence-based care vs best practice.
03:21 How the lack of comparing treatments head-to-head creates challenges for pathways.
04:30 Why community physicians are more accepting of pathways.
05:11 Winning the support of academic physicians.
06:49 What a pathway looks like.
08:43 How pathways are helping physicians run tests for diseases they normally wouldn’t run without it being inefficient.
10:21 How the pathways account for the patient’s choice.
11:50 Standardizing nationally and what these benefits are.
13:37 “We should all be approaching the same cases the same way.”
15:43 The barriers to standardizing.
17:06 “You really need strong leadership that says, ‘This is why this is so important.’”
20:39 “Pathways may actually not reduce costs.”
21:31 “The #1 goal is to improve patient outcomes.”
24:30 How clinical trials fit into pathways.

digital,healthcare,marketing,oncology,tech,via oncology,upmc,pathways,evidence-based care vs best practices,

Recent Episodes

Encore! EP384: How Shareholders Impact Carrier Behavior, Exactly and Specifically, With Wendell Potter
February 06, 202535:0132.05 MB

Encore! EP384: How Shareholders Impact Carrier Behavior, Exactly and Specifically, With Wendell Potter

I am drowning in all things Q1 right now. So, this week we’re going with an encore. But this is a great show to go back and reflect upon, as it’s about carriers and how shareholders impact the actions of said carriers. For a full transcript of this episode, click here . If you enjoy this podcast, b...

EP462: Managing Populations of Whole, Actual People Who Are Not the Sum of a Bunch of Different Body Parts, With Scott Conard, MD
January 30, 2025
462
33:3430.73 MB

EP462: Managing Populations of Whole, Actual People Who Are Not the Sum of a Bunch of Different Body Parts, With Scott Conard, MD

Hello, Tribe. I hope everyone is holding up in this Q1 where there is so much going on. I feel like I’m juggling 10 plates while running on a treadmill that keeps stopping and starting at random intervals. How you doing? For a full transcript of this episode, click here . If you enjoy this podcast,...

INBW42: A Philosophical Rabbit Hole of Considerations for Plan Sponsors and Others
January 23, 202527:3925.31 MB

INBW42: A Philosophical Rabbit Hole of Considerations for Plan Sponsors and Others

There have been two episodes lately that have sent me down a rabbit hole that I wanted to bring to your attention. Now, disclaimer: I know you people; you’re busy. You listen on average to, like, 26 minutes of any given episode. So, yeah … look at me being self-aware. I say all this to say welcome ...

EP461: Pick Only One, Plan Sponsors: Do You Want to Control GLP-1 Volume or Control GLP-1 Unit Cost? With Chris Crawford of RxSaveCard
January 16, 2025
461
22:4220.78 MB

EP461: Pick Only One, Plan Sponsors: Do You Want to Control GLP-1 Volume or Control GLP-1 Unit Cost? With Chris Crawford of RxSaveCard

This episode with Chris Crawford, CEO of RxSaveCard, is not about the when, why, or how of GLP-1s for weight loss or best-practice prescribing; and we do not wade into anything about lifestyle changes or who is adherent or clinical considerations and needed support. There are a plethora of shows on...

EP460: Rushika Fernandopulle, MD’s Theory of Change Starts With Status Quo Healthcare
January 09, 2025
460
41:0437.6 MB

EP460: Rushika Fernandopulle, MD’s Theory of Change Starts With Status Quo Healthcare

This is one of those episodes where we consider top-line strategic imperatives and key drivers. I thought there was no better person to do this with than Rushika Fernandopulle, MD, who, in case you were unaware, was the founder of Iora Health, an advanced primary care group that was sold to One Med...

EP459: Cost Containment by Co-Pay Maximizer or Co-Pay Accumulator: Points to Ponder, With Bill Sarraille
January 02, 2025
459
39:4736.41 MB

EP459: Cost Containment by Co-Pay Maximizer or Co-Pay Accumulator: Points to Ponder, With Bill Sarraille

If you have zero clue what co-pay maximizers and/or co-pay accumulators are and the financial incentives involved for PBMs (pharmacy benefit managers) and plan sponsors here, after you’re done listening to this episode, go back and listen to the show with Joey Dizenhouse ( EP423 ). Also, the episod...

INBW41: End-of-Year Wrap-Up and My Personal Charter Encore: Where the Rubber Hits the Road
December 26, 202425:5223.67 MB

INBW41: End-of-Year Wrap-Up and My Personal Charter Encore: Where the Rubber Hits the Road

Okay, so, we’re gonna go with personal charter. Just, yeah, given everything going on right now, yeah. It is a charter, not a manifesto. Because of the end-of-the-year status of this episode, I just want to kick this off by giving a big thank you to everyone listening. But this isn’t a thank you fo...

Listen and Follow

Sponsored by Aventria Health Group
©2025 BD Bridges LLC. All Rights Reserved.